1. Home
  2. HOWL vs HGBL Comparison

HOWL vs HGBL Comparison

Compare HOWL & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

48.1M

Sector

Health Care

ML Signal

HOLD

Logo Heritage Global Inc.

HGBL

Heritage Global Inc.

HOLD

Current Price

$1.35

Market Cap

41.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOWL
HGBL
Founded
2017
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
48.1M
41.6M
IPO Year
2021
1998

Fundamental Metrics

Financial Performance
Metric
HOWL
HGBL
Price
$0.98
$1.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$5.00
$3.85
AVG Volume (30 Days)
2.3M
204.7K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
18.40
N/A
EPS
N/A
N/A
Revenue
N/A
$20,129,000.00
Revenue This Year
N/A
$11.92
Revenue Next Year
N/A
$13.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$1.01
52 Week High
$2.23
$1.79

Technical Indicators

Market Signals
Indicator
HOWL
HGBL
Relative Strength Index (RSI) 66.96 58.96
Support Level $0.56 $1.34
Resistance Level $0.99 $1.42
Average True Range (ATR) 0.05 0.06
MACD -0.02 -0.00
Stochastic Oscillator 60.68 66.67

Price Performance

Historical Comparison
HOWL
HGBL

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It operates in four segments. The Auction and Liquidation segment, which operates as a full-service auction, appraisal, and asset advisory firm, includes the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment. The Refurbishment & Resale segment acquires, refurbishes, and supplies specialized laboratory equipment. Brokerage segment, through NLEX, brokers charged-off receivables in the U.S. and Canada on behalf of financial institutions. The Specialty Lending segment, which provides specialty financing solutions to investors in charged-off and nonperforming asset portfolios.

Share on Social Networks: